Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Electrically Insulative Structural Adhesive Is Chemically Resistant

July 30, 2010 6:33 am | Master Bond, Inc. | Product Releases | Comments

For superb adherence to a wide variety of substrates, including many metals, plastics, rubbers, ceramics, and glass, Polymer System EP31 was developed by Master Bond Inc.

Gearboxes Feature Low Speed, High Durability

July 30, 2010 6:27 am | Crouzet | Product Releases | Comments

Crouzet North America, a company of Custom Sensors & Technologies, has introduced a new line of single ovoid and double ovoid gearboxes. The new second generation gearboxes offer low speed in a wide range of gear ratios and motor options.

Charles River pulls plug on $1.6B buy of WuXi

July 30, 2010 5:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Charles River Laboratories International Inc. has called off its planned $1.6 billion purchase of Chinese research firm WuXi PharmaTech (Cayman) Inc. The board of Wilmington-based Charles River Labs has instead authorized the company to buy back up to $500 million of its own stock.

Advertisement

BioScrip 2Q profit slides on buyout and taxes

July 30, 2010 4:45 am | by The Associated Press | News | Comments

BioScrip Inc.'s net income fell 29 percent in the second quarter, the pharmacy benefits manager said Friday, because of an acquisition and higher taxes.Earnings per share were shaved by a penny because of the company's buyout of Critical Homecare Solutions. The company reported a...

30 million women to benefit from health reform law

July 29, 2010 10:37 pm | by EurekAlert | News | Comments

(Commonwealth Fund) Thirty million women will benefit from the new health reform law over the next decade, either through new or strengthened insurance coverage, according to a new report from The Commonwealth Fund. The law will stabilize and reverse the growing exposure to health...

TOPICS:

Clinical trials can be improved by managing the learning curve

July 29, 2010 10:34 pm | by EurekAlert | News | Comments

(Duke University Medical Center) Researchers at Duke University Medical Center looked for a learning curve phenomenon in the data record of a large, multi-site clinical trial. Their findings point to ways to improve the quality of future trials through better training and simulation exercises.

TOPICS:

Transforaminal steroid injection for lumbar radicular pain proves superior to placebo

July 29, 2010 10:33 pm | by EurekAlert | News | Comments

(Wiley-Blackwell) A recent study from Australian researchers determined that transforaminal injection of steroids was a viable alternative to surgery for lumbar radicular pain due to disc herniation. Full details of the study appear in the August issue of Pain Medicine, a journal...

TOPICS:

Gen-Probe 2Q net income rises 42 percent on sales

July 29, 2010 4:45 pm | by The Associated Press | News | Comments

Diagnostic test maker Gen-Probe Inc. said Thursday its second-quarter net income jumped 42 percent on higher revenue from blood screening and women's health products.The company earned $28.1 million, or 57 cents per share, up from $19.8 million, or 38 cents per share, during the same period a...

TOPICS:
Advertisement

Western diet link to ADHD

July 29, 2010 12:38 pm | by EurekAlert | News | Comments

(Research Australia) A new study from Perth's Telethon Institute for Child Health Research shows an association between ADHD and a "Western-style" diet in adolescents. The research findings have just been published online in the international Journal of Attention Disorders. Leader...

TOPICS:

FDA CONSUMER HEALTH INFORMATION - Keep Kids, Pets Away From Skin Sprayed With Evamist

July 29, 2010 12:37 pm | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md. , July 29 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) says children and pets should not come in contact with Evamist, a topical drug for women used in the treatment of hot flashes caused by menopause. (Logo:...

TOPICS:

Launch of BioOptimalâ„¢ MF-SL Microfilters for Bioprocessing

July 29, 2010 12:37 pm | by Bio-Medicine.Org | News | Comments

TOKYO , July 29 /- Asahi Kasei Medical Co., Ltd. is pleased to announce the commercial launch on August 1 of BioOptimal™ MF-SL, its new range of microfilters for bioprocessing applications. Designed specifically for use in cell culture clarification applications, BioOptimal™...

TOPICS:

Boston Scientific Announces FDA Approval of New Leads for the Precision Plusâ„¢ Spinal Cord Stimulator System

July 29, 2010 12:36 pm | by Boston Scientific | News | Comments

Company now offers pain specialists the most comprehensive portfolio of SCS percutaneous leads

TOPICS:

Evamist (estradiol transdermal spray): Drug Safety Communication - Unintended Exposure of Children and Pets to Topical Estrogen

July 29, 2010 12:31 pm | by U.S. Food & Drug Administration | News | Comments

Reports of adverse effects in children who may have been unintentionally exposed to the drug through skin contact with women using this product.

TOPICS:

Record results for Melexis in the second quarter of 2010

July 29, 2010 10:35 am | by I-Micronews | News | Comments

Intermediate declaration by the board of directors

Agios doubles staff, following Celgene deal

July 29, 2010 10:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Agios Pharmaceuticals Inc. has doubled in size following its deal with Celgene Corp., which was announced in April. The Cambridge-based company's head count now stands at around 45 workers, up from 22 before the deal, and Agios officials say the company will keep growing.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading